The size of clinical trials in cancer research – what are the current needs?
- 1 March 1989
- journal article
- Published by Springer Science and Business Media LLC in British Journal of Cancer
- Vol. 59 (3), 396-400
- https://doi.org/10.1038/bjc.1989.79
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Effect of intravesical mitomycin C on recurrence of newly diagnosed superficial bladder cancer: interim report from the Medical Research Council Subgroup on Superficial Bladder Cancer (Urological Cancer Working Party)BMJ, 1988
- Endoscopic coagulation of upper gastrointestinal haemorrhage, one; randomised clinical trials, two.BMJ, 1987
- Why do we need systematic overviews of randomized trials? (Transcript of an oral presentation, modified by the editors)Statistics in Medicine, 1987
- The Effect of Adjuvant Chemotherapy on Relapse-Free Survival in Patients with Osteosarcoma of the ExtremityNew England Journal of Medicine, 1986
- Why do we need some large, simple randomized trials?Statistics in Medicine, 1984
- Osteogenic sarcoma: eight-percent, three-year, disease-free survival with combination chemotherapy (T-7).1981
- Theological interference in medicine.1978
- Adjuvant therapy for osteosarcoma: preoperative and postoperative treatment.1978
- Amputation and Adriamycin in Primary OsteosarcomaNew England Journal of Medicine, 1974
- The veterans administration cooperative urological research group's studies of cancer of the prostateCancer, 1973